Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
08/2004
08/25/2004CN1523028A Novel phosphonate-nucleotide compound
08/25/2004CN1523019A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents
08/25/2004CN1522703A Yolk lecithin for injection and method for making same
08/25/2004CN1163541C Preparation method of rganic phosphorous composition and organic phosphorous compound and polyester composition and preparation method thereof
08/25/2004CN1163499C Process for racemization of atropisomeric bis(phosphine oxide) compound
08/25/2004CN1163498C Preparation method for high-purity bisalkyl phosphate ester
08/25/2004CN1163496C Vinyl-pyrrolidone cynnematin with alkali subtituent
08/25/2004CN1163463C Preparation of aldehyde
08/25/2004CN1163408C Process and apparatus for producing phosphine-containing gas
08/24/2004US6781011 Bone-related and various other diseases
08/24/2004US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents
08/24/2004US6780982 Charge tags and the separation of nucleic acid molecules
08/19/2004WO2004069146A2 L-dopa amide derivatives and uses thereof
08/19/2004WO2004050620A3 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
08/19/2004WO2004048393A3 NOVEL INHIBITORS OF β-LACTAMASE
08/19/2004WO2003053918A3 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof
08/19/2004US20040162362 Acidity and dissociation; stability, for doping polymers, as electrolytes in batteries
08/19/2004US20040162329 Structural carotenoid analogs for the inhibition and amelioration of disease
08/19/2004US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
08/19/2004US20040161751 A radioactive 32P or 33P phosphine oxide ligand that is useful for radioreceptor binding studies and for diagnostic studies of cancerous tissues; the receptor confers selectively and specificity in delivering lethal radiation to diseased cells
08/19/2004US20040161520 Purification; mixture of phospholipids, oil and sugar; mixing ethanol and water; solvent extraction
08/19/2004US20040161398 Compositions and methods for targeting cancer cells
08/18/2004EP1447396A1 Phthalic acid diamide derivatives, agriculture and horticultural insecticides, and a method for application of the insecticides
08/18/2004EP1446410A1 Multimer forms of acylphosphines and their derivatives
08/18/2004EP1446405A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
08/18/2004EP1446224A2 Aromatic compounds containing nitrogen and p-functionalized amines, the production thereof and their use in catalytic reactions
08/18/2004EP1252170B1 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
08/18/2004EP1030854B1 Catalysts for asymmetric synthesis containing rigid chiral ligands
08/18/2004CN1522262A Process for the production of pentaerythritol phosphate alcohol
08/18/2004CN1522171A Compositions of alkanolamine salts of alkyl phosphate esters
08/18/2004CN1521173A Method for producing chlorpyrifos
08/18/2004CN1162410C Insecticidal dihydro-oxadiazines, -thiadiazines and triazines
08/18/2004CN1162221C Catalyst comprising complex of metal of subgroup viii Based on phosphinite ligand, and method for hydrogormylation
08/17/2004US6777578 Inhibitor of tubulin polymerization; antineoplastic activity
08/17/2004US6777567 Ferrocenyl diphosphines and their use
08/17/2004US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them
08/17/2004US6777433 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
08/17/2004US6776977 Polypodal chelants for metallopharmaceuticals
08/12/2004WO2004067541A1 Industrial process for the synthesis of 2-substituted 1-(hydroxy-ethylidene)-1,1-bisphosphonic acids of high purity and the salts thereof
08/12/2004WO2004067540A1 Novel compounds capable of forming photoconvertible organic thin films and articles having organic thin films
08/12/2004WO2004067505A2 Bismuth dithiocarbamate compounds and uses thereof
08/12/2004WO2004067489A2 Hydroxyl compounds and compositions for cholesterol management and related uses
08/12/2004WO2004067483A2 Chelating agents with lipophilic carriers
08/12/2004WO2004066959A2 Organic-arsonic compounds
08/12/2004WO2004010846A3 Design and synthesis of renal dipeptidase inhibitors
08/12/2004WO2003092374A3 Pesticidal heterocycles
08/12/2004US20040158098 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
08/12/2004US20040158091 Method for producing perfluoroalkanesulfonic acid esters
08/12/2004US20040157806 4-Dedimethylamino tetracycline compounds
08/12/2004US20040157800 for preventing the onset of or treating a condition of panniculitide
08/12/2004US20040157344 Multistage sensitive detection
08/12/2004US20040157247 Of given formula; used to build up oligomers which can be used for hybridization, probes and detection of nucleic acids; protecting groups, fluorescent dyes, solid phase, phosphoramidite, phosphonate or triphosphate
08/12/2004US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain
08/12/2004US20040156795 Dental self-etching primer
08/12/2004US20040156786 Paramagnetic complexes as contrast agents for magnetic resonance imaging; chelate compounds
08/12/2004CA2514201A1 Chelating agents with lipophilic carriers
08/11/2004EP1445019A1 Hydroformylation of unsaturated compounds using polymeric phosphite ligands
08/11/2004EP1444310A1 Flame-retardant compositions of methanephosphonic acid, boric acid and an organic base
08/11/2004EP1444241A2 Bidendate ligands for the carbonylation of unsaturated compounds
08/11/2004EP1444215A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/11/2004EP1444176A2 Bidentate ligand for the telomerization of dienes
08/11/2004EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
08/11/2004EP1353930B1 Method for producing n-phosphonomethyl iminodiacetic acid
08/11/2004EP1320535B1 Method for isolating pharmaceutically exploitable etidronate disodium
08/11/2004EP1242467B1 Synthesis method for polymers by controlled radical polymerisation with xanthates
08/11/2004EP1027713A4 Nonaqueous electrolyte for electrical storage devices
08/11/2004CN1520298A Pyrazolopyrimidines as therapeutic agents
08/11/2004CN1519240A Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
08/11/2004CN1161364C Cyclopentadienyl/phosphinimine catalyst with one and only one activatable ligand
08/11/2004CN1161363C Diphosphonic acid salts for treatment of osteoporsis
08/11/2004CN1161330C Taurine-metal ion match and its preparing process
08/10/2004US6774265 Bis-phosphonium salt and process for producing the same
08/10/2004US6774257 Bis (aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof
08/10/2004US6774254 Gold complexes
08/10/2004US6774163 Flame retardants for polymers comprising a mixture of two different aryl phosphates, their preparation and their use
08/10/2004US6774142 May be administered along with rutin, a rutin congener and/or a rutin derivative.
08/10/2004US6774133 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
08/10/2004US6774126 Pyrrolo[1,2-b][1,2,4]oxadiazine diones useful as nitric oxide synthase inhibitors
08/10/2004US6774121 Phospholipid prodrugs of anti-proliferative drugs
08/10/2004US6773624 Process for the preparation of hindered phosphites
08/05/2004WO2004065397A1 Risedronate sodium having a very low content of iron
08/05/2004WO2004065396A2 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds
08/05/2004WO2004065369A1 Carboxamide derivatives and their use as factor xa inhibitors
08/05/2004WO2004064683A1 Stent with variable stiffness
08/05/2004WO2004040534A3 Metal chelates and methods of using them for time-resolved fluorescence
08/05/2004WO2003091688A3 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine n-oxides, and phosphine oxide-pyridine n-oxides, and devices made with such complexes
08/05/2004WO2003000187A3 Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
08/05/2004US20040152926 Process for producing fluorinated alcohol
08/05/2004US20040152916 Process for the preparation of 4-amino-1-hydroxybutylidene-1,1-biphosphonic acid
08/05/2004US20040152913 Cleavable surfactants and methods of use thereof
08/05/2004US20040152910 Separation; purification; crystallization
08/05/2004US20040152770 Highly-packed polycationic ammonium, sulfonium and phosphonium lipids
08/05/2004US20040152745 Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
08/05/2004US20040152698 Heterocyclic carboxamides and their use as fungicides
08/05/2004US20040152671 Novel quinolines and uses thereof
08/05/2004US20040152646 Useful in therapy of disorders which are responsive to the opening of potassium channels such as ischemia, stroke, convulsions, asthma, epilepsy, irritable bowel syndrome, migraine, traumatic brain injury, spinal cord injury, sexual dysfunction
08/05/2004DE10304158A1 New transition metal complexes with azo ligands, useful as catalysts, particularly for polymerization of olefins, especially in presence of polar additives
08/05/2004CA2514100A1 Carboxamide derivatives and the use thereof as factor xa inhibitors
08/05/2004CA2513543A1 Risedronate sodium having a very low content of iron
08/05/2004CA2512723A1 Stent with variable stiffness